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Functional Expression Cloning of Nanog,
a Pluripotency Sustaining Factor
in Embryonic Stem Cells
mediated via coculture with a feeder layer of embryo
fibroblasts or provision of a cytokine such as leukemia
inhibitory factor (LIF) that acts through the LIF-R/gp130
complex (Yoshida et al., 1994; Burdon et al., 1999a).
LIF-deficient fibroblasts are reported to be incapable of
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King’s Buildings supporting ES cell self-renewal (Stewart et al., 1992),
indicating that supply of LIF is a key attribute of feeders.West Mains Road
Edinburgh EH9 3JQ However, although no self-renewal factors have been
identified other than gp130 cytokines, there is evidenceScotland
for operation of a gp130-independent pathway that can
maintain ES cell identity (Dani et al., 1998). Furthermore,
self-renewal of human blastocyst-derived stem cells ap-Summary
pears not to be maintained by LIF (Thomson et al., 1998;
Reubinoff et al., 2000). Finally, gp130 signaling is dis-Embryonic stem (ES) cells undergo extended prolifera-
pensable for pluripotent cells in the mouse embryo be-tion while remaining poised for multilineage differenti-
cause null mutants undergo gastrulation and organo-ation. A unique network of transcription factors may
genesis. A requirement for gp130 is only revealed if thecharacterize self-renewal and simultaneously sup-
schedule of embryo implantation is delayed (Nichols etpress differentiation. We applied expression cloning in
al., 2001). Thus, the gp130 pathway serves a facultativemouse ES cells to isolate a self-renewal determinant.
role in vivo, and is not fundamental to pluripotency.Nanog is a divergent homeodomain protein that di-
Recent studies have begun to define key players inrects propagation of undifferentiated ES cells. Nanog
the transcriptional specification of the mouse ES cellmRNA is present in pluripotent mouse and human cell
phenotype. Essential roles have been assigned tolines, and absent from differentiated cells. In preim-
gp130-mediated activation of Stat3 (Niwa et al., 1998;plantation embryos, Nanog is restricted to founder
Matsuda et al., 1999) and to the intrinsic activity of thecells from which ES cells can be derived. Endogenous
POU factor Oct4 (Niwa et al., 2000). However, Stat3 isNanog acts in parallel with cytokine stimulation of
not ES cell-specific but is found in a variety of other cellStat3 to drive ES cell self-renewal. Elevated Nanog
types, often associated with differentiation (Hirano etexpression from transgene constructs is sufficient for
al., 2000). Oct4 is restricted to pluripotent and germ lineclonal expansion of ES cells, bypassing Stat3 and
cells (Pesce and Scho¨ler, 2001), but forced constitutivemaintaining Oct4 levels. Cytokine dependence, multi-
expression of Oct4 is not sufficient to prevent ES celllineage differentiation, and embryo colonization ca-
differentiation (Niwa et al., 2000). Oct4 and Stat3 eachpacity are fully restored upon transgene excision.
interact with various cofactors and regulate expressionThese findings establish a central role for Nanog in
of multiple target genes. Which of these interactionsthe transcription factor hierarchy that defines ES cell
and targets are important for the ES cell phenotype isidentity.
presently unknown. Nor do the existing data preclude a
central role for another transcriptional regulator. Indeed,
Introduction the finding that overexpression of Oct4 induces differen-
tiation similar to withdrawal of LIF is suggestive of an
Mouse embryonic stem (ES) cells are permanent cell intersection between Stat3 and Oct4 that could be medi-
lines derived from the preimplantation embryo (Evans ated by a “master” transcriptional organizer (Niwa et al.,
and Kaufman, 1981; Martin, 1981). These cells have 2000; Niwa, 2001).
three hallmarks: they undergo symmetrical self-renew- We sought to identify gene functions capable of di-
ing divisions, they are pluripotent with capacity to differ- recting mouse ES cell propagation. Functional screen-
entiate into all fetal and adult cell lineages, and they can ing of an ES cell cDNA library resulted in isolation of a
incorporate into embryos and contribute to functional divergent homeodomain protein that acts as an intrinsic
tissue generation. Surprisingly, however, the intrinsic effector of ES cell self-renewal. This homeobox gene is
biology of these extraordinary cells remains poorly de- also expressed in the founder cells of the early embryo.
scribed (Smith, 2001). In particular, the molecular foun- Accordingly, we have named the gene nanog, after the
dations of cellular pluripotency have not been defined, mythological Celtic land of the ever young, Tir nan Og.
much less integrated, to provide a mechanism that can
explain the robust preservation of stem cell identity and Results
potency during ES cell propagation.
At each ES cell division, the alternative outcomes of A Functional Screen for ES Cell
self-renewal and differentiation are decided by the inter- Self-Renewal Determinants
play between intrinsic factors and extrinsic instructive To undertake a functional library screen in ES cells,
or selective signals. Propagation of mouse ES cells is we exploited a system for episomal transduction and
expression of cDNAs. This is based on the replicative
functions of the polyoma virus (Gassmann et al., 1995).*Correspondence: ichambers@ed.ac.uk
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Figure 1. Components of the Expression Cloning Strategy
(A) pPyCAGIP episomal expression vector. The plasmid carries a polyoma origin with the F101 mutation allowing episomal replication in ES
cells. cDNA is cloned directionally in place of the stuffer fragment within a transcription unit linked to the puromycin resistance gene (pac)
through an IRES.
(B) Reduced background of self-renewal in ES cells deleted for the lifr gene. E14/T or the lifr targeted subclone, LRK1, were transfected with
pPyCAGIP and plated at 106 per 9 cm petri dish. Selection was applied 30 hr later and plates stained for alkaline phosphatase after 12 days.
(C) Logic of the expression strategy. Plasmid directing ES cell self-renewal amplifies during ES cell propagation and can be recovered and
enriched by further rounds of selection in ES cells.
(D) Colonies of LRK1 cells expressing Nanog cDNA from the pPyCAGIP episome in the absence of cytokine; left, colony morphology; right,
in situ hybridization for Oct4 mRNA.
(E) Quantitation of stem cell colonies formed following transfection of LRK1 cells with pPyCAGIP derivatives carrying no insert (0), Nanog
cDNA, or Nanog ORF. Data are the average of at least three independent experiments; bars indicate standard deviations.
ES cells that express polyoma large T antigen can rou- When LIFR-negative ES cells were plated onto MEF
feeder cells, a number of small, undifferentiated coloniestinely be “supertransfected” with plasmids carrying a
polyoma origin of replication (ori) at a frequency of 1%, reproducibly emerged. Thus, while the major self-
renewal activity derived from MEFs acts via LIFR, an-three orders of magnitude greater than DNA integration
efficiencies in ES cells. A cDNA expression library of 105 other mechanism(s) of sustaining ES cell propagation
is operative. Consequently, we prepared a cDNA libraryindependent plasmids can therefore be screened by
episomal transfection of 107 cells. Provided selection from ES cell/MEF cocultures.
LRK1 cells were transfected with library DNA and cul-is maintained, episomal propagation of the transfected
DNA can be sustained for several weeks, allowing facile tured in the absence of cytokine according to the strat-
egy outlined in Figure 1C. Two pools were identifiedrecovery of DNA conferring a phenotype of interest. Ad-
ditionally, robust cDNA expression is assured by avoid- that yielded morphologically undifferentiated colonies.
Further analysis indicated that the active cDNA in bothance of epigenetic effects arising from chromosomal
integration. pools encoded the same cDNA. Transfection of purified
plasmid DNA produced self-renewing ES cell coloniesOf various episomal constructs we have tested, the
pPyCAGIP plasmid (Figure 1A) gives the highest levels that expressed Oct4 (Figure 1D). The biological activity
of the cDNA resides within the open reading frame (Fig-of cDNA expression. Puromycin selection rapidly elimi-
nates untransfected ES cells removing a source of po- ure 1E).
tentially confounding biological activities. However, in
the absence of added LIF, supertransfection with empty
pPyCAGIP vector yields mixed colonies containing un- Characterization of the Nanog cDNA
A search for recognizable domains in the ORF usingdifferentiated ES cells. This is due to production of LIF
by differentiated cells (Rathjen et al., 1990). In order to SMART (http://smart.embl-heidelberg.de) revealed the
presence of a homeodomain between amino acid resi-eliminate this background, the lifr gene was deleted.
LRK1 cells are maintained as undifferentiated ES cells dues 96 and 155, with no other obvious relationship to
previously characterized proteins. A maximum of 50%by activation of gp130 using IL6/sIL6R. Compared to
parental E14/T cells, they produce negligible stem cell amino acid identity over the homeodomain is found with
Barx1, Msx1, and members of the NK2 family of homeo-colonies when transfected with empty vector in the ab-
sence of cytokine (Figure 1B). proteins, with no conserved motifs outside the homeo-
Identification of ES Cell Determination Gene
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Figure 2. Sequence Analysis of Nanog cDNA
(A) Alignment of the Nanog homeodomain
with closely related representatives from sev-
eral classes of homeodomain protein. The
alignment was generated with Clustal W and
shaded with respect to Nanog: orange, identi-
cal in all sequences; green, identical to Nanog;
yellow, similar to Nanog. Percent identities to
the Nanog homeodomain are shown on the
right.
(B) Alignment of full-length mouse (Mm)
Nanog with the human (Hs; accession num-
ber NP_079141) and rat (Rn) orthologs. The
rat protein is predicted from the rat chromo-
some 4 sequence NW_043769. The alignment
was generated with Clustal W: orange, identi-
cal in all sequences; green, identical in 2 se-
quences; yellow, similar in 2 sequences. The
homeodomain is underlined.
(C) The 3 UTR of the mouse Nanog cDNA
contains a B2 repeat. Numbering is according
to Nanog cDNA and B2 sequence accession
number K00132; differences are in red type.
Asterisks indicate positions at which the
Nanog cDNA sequence differs from a C57BL/
6J derived cDNA (Genbank accession
#AK010332). Whether the B2 sequence is
transcribed in reverse orientation to Nanog
by RNA polymerase III is unclear, although
the sequence of split promoter (boxed in red)
suggests that it may be (Galli et al., 1981).
(D) Activity of human Nanog in mouse ES cells.
LRK1 cells were transfected with pPyCAGIP
with no insert or carrying hNanog ORF. Alka-
line phosphatase-positive colonies in the ab-
sence of cytokine are presented as a percent-
age of the number formed in the presence of
IL6/sIL6R.
domain (Figure 2). The protein thus appears to be a C-terminal. In addition, the mouse sequence from resi-
dues 198–243 has a tryptophan at every fifth position.unique variant homeoprotein, which we named Nanog.
Orthologs of Nanog were identified by BLAST in the Despite a short insertion (rat) or deletion (human), the
spacing of tryptophans is conserved, although one ofrat (87% identity) and human (58% identity). Sequence
conservation was most pronounced over the homeodo- the tryptophans in the human is replaced by a glutamine.
The first 31 amino acids of the tryptophan repeat in themain where identities were 94% (rat) and 87% (human)
(Figure 2B). Outwith the homeodomain are 4 conserved two rodent sequences represent a simple reiteration of
WnsQTWTNPTW (n  G,S,N and s  S,N).regions of 5 or more contiguous amino acids. A serine-
rich motif is N-terminal to the homeodomain, the others A B2 repetitive element is present in the 3 UTR of
Cell
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Figure 3. Expression of Nanog in Pluripotent Cell Lines
(A) Hybridization of RNA from MEFs and from MEF/ES cell cocultures used for library construction. 1 g pA RNA was loaded per lane and
hybridized with probes for Nanog cDNA (left), GAPDH (right), and Nanog ORF (middle). Positions of RNA markers (kb) are shown to the left.
(B) Nanog in situ hybridization of a MEF/ES cell coculture (left) and a feeder-free culture in which an undifferentiated cluster of ES cells is
surrounded by differentiated cells (right); bars are 50 m.
(C) Nanog expression in cell lines. RNAs were from PSMB, PC13.5, F9, PSA4 and P19 EC cells; CGR8, ES cells; PE, D7-A3 parietal endoderm-
like; EG, embryonic germ cells; PYS, parietal yolk sac; NIH3T3, fibroblasts; BAFB03, pro-B cells; MEL, erythroleukaemia; B9, plasmacytoma.
(D) Human nanog RNA is expressed in EC cells. RNAs were from embryonal carcinoma (GCT27) (Pera et al., 1989) and lymphoid (Jurkat) cells.
(E) Nanog is downregulated during ES cell differentiation. E14Tg2a cells were induced to differentiate by application of retinoic acid (RA) or
3-methoxybenzamide (MBA) for the number of days shown.
(F) Lack of detectable Nanog mRNA in adult tissues. RNAs were: 1, CGR8 ES cells; 2, adipose; 3, kidney; 4, liver; 5, heart; 6, spleen; 7, brain;
8, bone marrow; 9, tongue; 10, eye; 11, oviduct; 12, thymus; 13, skeletal muscle; 14, skin; 15, ovary; 16, seminiferous vesicle; 17, lung.
Northern analysis was performed by sequential hybridization with probes for nanog, GAPDH, and oct4 (C and E), hnanog and GAPDH (D),
and nanog and GAPDH (F).
the Nanog mRNA (Figure 2C). This could contribute to carcinoma cell lines (Figure 3C). P19 EC cells showed
reduced Nanog expression. Human Nanog mRNA wasregulation of Nanog gene expression, since B2 elements
detected in embryonal carcinoma cells but not lymphoidare expressed at high levels in embryonic cells (Ryskov
cells (Figure 3D). During ES cell differentiation, Nanoget al., 1983).
mRNA declined markedly (Figure 3E). In situ hybridiza-The ability of the putative human Nanog ortholog to
tion of partially differentiated ES cell cultures showedfunction in mouse ES cells was tested by transfecting
that Nanog expression was retained only in undifferenti-LRK1 cells. Although less effective than mouse Nanog,
ated cells (Figure 3B, right). Nanog transcript was unde-the human sequence was capable of directing cytokine-
tectable in various adult mouse tissues by Northern hy-independent self-renewal (Figure 2D). We also tested
bridization of total RNA (Figure 3F).the ORF of Nkx2.5, one of the mouse homeobox genes
We investigated distribution of Nanog mRNA in themost closely related to Nanog. No cytokine-independent
mouse embryo (Figure 4). No expression is evident dur-stem cell colonies formed; in fact, Nkx2.5 transfectants
ing early cleavage stages. The first sign of Nanog mRNAappeared morphologically differentiated even in the
is in compacted morulae. Strikingly, the hybridizationpresence of LIF. Thus, cytokine independence is specifi-
signal is localized to interior cells, the future inner cellcally conferred by Nanog and is not a common attribute
mass (ICM). Blastocyst expression is confined to theof homeodomain proteins.
ICM and absent from the trophectoderm. In later blasto-
cysts, Nanog mRNA is further restricted to the epiblast
Nanog mRNA Appears Confined to Pluripotent and excluded from the primitive endoderm. By implanta-
Tissues and Cell Lines tion stage, Nanog mRNA is downregulated.
Nanog mRNA is expressed in ES cell/MEF cocultures We also examined Nanog expression in primordial
but not by MEFs alone (Figure 3A). We eliminated hybrid- germ cells, which can be converted into pluripotent EG
ization of the Nanog cDNA to small B2 transcripts using cells (Matsui et al., 1992; Resnick et al., 1992). Expres-
a probe restricted to the Nanog ORF and employed this sion is readily detectable in the genital ridges of E11.5
in all subsequent analyses. In situ hybridization con- embryos (Figure 4B).
firmed that ES cells were the source of expression in
coculture (Figure 3B). Nanog mRNA was not detected ES Cell Identity Is Faithfully Maintained
in parietal endoderm, fibroblast, and hematopoietic cell by Nanog Expression
lines, but was abundant in ES cells, EG cells, and in We introduced nanog into ES cells that do not contain
polyoma LT. A loxP-containing construct was employedboth LIF-dependent and LIF-independent embryonal
Identification of ES Cell Determination Gene
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transfectants were isolated and expression of transgene
mRNA confirmed (Figure 5B). Cells were then seeded
at low density and expanded in the presence of the LIF
antagonist, hLIF-05 (Vernallis et al., 1997) for at least
7 days. hLIF-05 blocks the activity of all known LIF-R
ligands. Parental cells treated in parallel underwent
complete differentiation, yielding no passageable colo-
nies. In contrast, cells expressing the nanog-IRES-pac
cassette continued to proliferate as undifferentiated
stem cells. Subsequently, cells were transiently trans-
fected with Cre in the presence of LIF. Colonies in which
the Nanog expression cassette had been eliminated
were identified by expression of GFP and restoration
of puromycin sensitivity. Chromosomal spreads were
examined for several clones and in all cases found to
be predominantly 40XY.
Colony assays were used to evaluate the phenotype
of Nanog transfectants and their Cre-treated derivatives.
From 25%–50% of colonies produced by parental ES
cells in the presence of LIF can be classified as pure
stem cell colonies, consisting solely of alkaline phospha-
tase positive undifferentiated cells, by the end of this 6
day assay. In the absence of LIF, parental ES cells form
only differentiated cell colonies. Nanog transfectants,
however, generated appreciable numbers (30%) of
pure stem cell colonies even in the presence of hLIF-
05, which blocks juxtacrine LIF activity. Cre-treated cells
reverted fully to LIF dependence, demonstrating that
this phenotype is directly attributable to Nanog overex-
pression. Similar observations were made for multiple
different clones (Figure 5C).
In the presence of LIF, differentiation of Nanog-
expressing cells was further reduced and the proportion
of pure stem cell colonies rose to 60% (Figure 5C).
This was accompanied by a change in the colony growth
characteristics of the cells (Figure 5D). Without LIF, the
Nanog expressers formed flat colonies of adjoining
small cells with a scant cytoplasm that were indistin-
guishable from parental or Cre-reverted ES cell colonies
in the presence of LIF. Addition of LIF caused the Nanog
colonies to adopt a more tightly packed morphology in
Figure 4. Expression of Nanog In Vivo
which the cells preferentially adhered to one another
(A) Preimplantation embryos. Top: embryos of 1, 2, and 6 cells. rather than growing out as an even monolayer over the
Middle: 8-cell embryo, late morula and early blastocyst. Bottom:
substratum. These compact colonies resembled ESblastocysts at expanded, hatched, and implanting stages. Embryos
cells cultured on feeder layers or on uncoated plastic.were hybridized in the same reaction and stained for the same time.
We then challenged Nanog expressers with agentsAll panels are shown at equal magnification.
(B) E11.5 genital ridges from female (top) and male (bottom) em- that promote differentiation. Following exposure to 3-meth-
bryos. Hybridization appears localized to the primordial germ cells oxybenzamide (MBA) or all-trans retinoic acid (RA), most
overlying the somatic tissue. Nanog expressing cells remained morphologically un-
differentiated, whereas cultures of both Cre revertants
and parental cells underwent widespread differentiation
within 4 days. This was reflected at the molecular level
such that the nanog cDNA could subsequently be ex- in continued expression of Oct4 by Nanog expressers
cised by Cre recombinase simultaneously bringing GFP compared with downregulation in Cre derivatives (Figure
under CAG promoter control (Figure 5A). Excision of the 6A). Therefore, Nanog transfectants are resistant, though
nanog cassette controls for any genetic or epigenetic not completely refractory, to chemical induction of dif-
changes associated with either the transfection and se- ferentiation in monolayer cultures. Normal differentiation
lection process or directly with the transgene. We first responsiveness was restored following transgene ex-
tested the ability of cells overexpressing Nanog to be cision.
propagated clonally in the absence of gp130 signaling We examined the capacity for neuroectodermal differ-
and then examined whether pluripotency and embryo entiation. Cells were aggregated and exposed to retinoic
colonization capacity were sustained. acid, then plated on laminin-coated plastic (Li et al.,
The following procedure was performed with two in- 1998). E14Tg2a parental cells gave rise to abundant
neuronal cells that expressed neuron-specific type IIIdependent ES cell lines, E14Tg2a and ZIN40. Clonal
Cell
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Figure 5. Reversibility of gp130 independent self-renewal
(A) Schematic of floxed Nanog expression vector. The LoxP sites are positioned in the second exon of the CAG cassette and between the
terminator sequence and egfp such that following Cre-mediated recombination CAG directs expression of egfp.
(B) Northern analysis before and after Cre excision. The blot was hybridized sequentially with the indicated probes. EF1, E14Tg2a subclone
carrying the floxed transgene; EF1C1, EF1 subclone following Cre-mediated excision.
(C) Removal of Nanog cassette restores LIF dependence. Parental ES cells, transfectants expressing the nanog transgene, and their Cre-
excised derivative lines were analyzed following plating at clonal density in the indicated culture conditions; 0, no addition; LIF, 100 U/ml LIF,
hLIF-05, LIF antagonist. After 6 days culture, pure alkaline phosphatase positive colonies were quantitated; left, E14Tg2a and derivatives,
data are the means of at least three determinations; right, Zin40 and derivatives, single determinations from a representative experiment.
(D) Morphology of Nanog-expressing cells and Cre-excised derivative in the absence of cytokine (0), in 100 U/ml LIF (LIF) or in the presence
of hLIF-05.
-tubulin (TuJ). In Nanog-expressing EF4 cells, the inci- These observations indicate that differentiation of ES
cells expressing Nanog is significantly suppressed. Cru-dence of TuJ-positive cells was greatly reduced, but
neuronal differentiation was fully restored in Cre re- cially, the Cre derivative cell lines appear unaffected
by the period of clonal expansion driven by enhancedvertants (Figure 6B). Similar results were observed in
three separate trials. Nanog expression, since under all conditions examined,
Identification of ES Cell Determination Gene
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Figure 6. Nanog Transfectants Retain ES
Cell Identity
(A) Oct4 Northern analysis of RNA from cul-
tures of E14Tg2a derivatives expressing the
floxed transgene (EF4) or a Cre-excised sub-
clone (EF4C3) prepared at 0, 1, 2, 3, or 4 days
following exposure to RA or MBA.
(B) Nanog suppresses neuronal differentia-
tion. E14Tg2a, transfectant EF4 expressing
the floxed Nanog transgene, and Cre-excised
subclone EF4C3 were assessed by TuJ im-
munohistochemistry 2 days after plating reti-
noic acid treated aggregates.
(C) Contribution of Cre-deleted cells to mid-
gestation embryo. Fetus generated from an
MF1 blastocyst injected with EF1C1 cells and
examined at E9.5 for green fluorescence.
(D) Adult chimera generated by injection of
EF4C3 cells into C57BL/6 blastocyst.
they displayed comparable differentiation efficiency to per cell based on similar studies measuring GFP produc-
tion (data not shown). Furthermore, as observed for cellsparental ES cells.
Finally, we investigated whether forced expression carrying integrated Nanog transgenes, the addition of
LIF to cultures of cells carrying Nanog episomes aug-of Nanog bypasses the requirement for LIF-R/gp130-
mediated signaling in maintenance of embryo coloniza- mented self-renewal assessed in terms of both the num-
ber and morphology of self-renewing colonies. Similartion properties. EF1C and EF4C Cre-reverted Nanog
transfectants were injected into mouse blastocysts. Ex- results were obtained by transfection of the same DNAs
into the CCE-derived polyoma large T-expressing cellamination at mid-gestation demonstrated widespread
contribution of ES cell derivatives to tissues of the devel- line MG1.19 (Gassmann et al., 1995).
We investigated whether Nanog might act through theoping fetuses as revealed by GFP expression (Figure
6C). Injected embryos were also brought to term and Jak/Stat pathway. First, we used the specific inhibitor
D6665. Treatment with concentrations (0.1–0.3 M) pre-resulted in the production of live chimeras from both
clones (Table 1 and Figure 6D). viously shown to block Jak activity and Stat phosphory-
lation (Thompson et al., 2002) caused complete differen-These results establish: (1) that cells expressing the
tiation of parental ES cells in the presence of LIF. InNanog transgene self-renew in a cytokine-independent
contrast, Nanog expressers formed undifferentiated col-manner, (2) that LIF can combine with the Nanog trans-
onies though the additive effect of LIF was reduced orgene to confer enhanced self-renewal capacity, and (3)
abolished (Figure 7B). We then examined activation ofthat the effects of Nanog transgene expression are fully
Stat3 directly. Steady-state levels of active Stat3 in pa-reversed following transgene excision.
rental ES cells, Nanog expressers, and Cre-reverted
cells were determined by immunoblotting. Stat3 activa-
Relationship of Nanog with Other tion in the presence of LIF is not substantially increased
ES Cell Regulators in Nanog expressers (Figure 7C). More significantly, on
ES cells normally express Nanog, yet this is not sufficient withdrawal of LIF, the low basal level of active Stat3 is
to sustain self-renewal upon LIF withdrawal, suggesting not enhanced. Furthermore, addition of hLIF-05 to block
that the dosage of Nanog may be critical. We transfected autocrine LIF eliminated tyrosine phosphorylated Stat3
LRK1 cells with episomal constructs directing differing in parental and reverted ES cells and equally effectively
levels of cDNA expression (Figure 7A). The proportion in Nanog expressers. Thus, active Stat3 is undetectable
of self-renewing colonies in the absence of cytokine under conditions in which Nanog-expressing ES cells
correlated with the relative expected level of expression can be clonally propagated.
The combined effect of LIF and Nanog suggests that
Nanog is not simply a downstream effector of gp130. We
investigated directly whether Nanog is a transcriptionalTable 1. Live-Born Chimeras Obtained from Cre Derivatives
target of LIF/gp130 signaling, taking advantage of chi-of Nanog Transfectants
meric receptors in which Stat3 activation is either abol-
Line Mice born Chimeras ished or enhanced (Burdon et al., 1999a). SOCS3 pro-
EF1C1 7 3 vides a control Stat3 target gene that is induced in ES
EF1C3 21 10 cells by LIF. SOCS3 induction is eliminated when the
EF1C5 11 11 four Stat binding sites in a chimeric receptor (Y126-
EF4C3 3 3
275F) are mutated (Figure 7D). Hyperactivation of Stat3
Cell
650
Figure 7. Relationship of Nanog to Other Known Mediators of Self-Renewal
(A) Generation of stem cell colonies correlates with level of Nanog expression. LRK1 cells were transfected with episomal vectors expected
to direct increasing levels of expression of Nanog (pPyPPGK  pPyPCAG  pPyCAGIP). Following selection, the proportion of stem cell
colonies in the absence of cytokine is expressed relative to the number in the presence of IL6/sIL6R. Data are the averages and standard
deviations of three determinations.
(B) Nanog sustains self-renewal in the presence of Jak inhibitor. Parental ES cells, transfectants expressing the nanog transgene, and Cre-
excised derivatives were plated at clonal density in medium containing 100 U/ml LIF with D6665 at 0, 0.1, or 0.3 M. After 6 days culture, the
percentages of pure alkaline phosphatase-positive colonies were quantitated.
(C) Nanog does not activate Stat3. Parental ES cells, transfectants expressing the nanog transgene, and Cre-excised derivatives were plated
at 105 cells/cm2 and incubated overnight in medium containing no addition (0), hLIF-05 (h), or 100 U/ml LIF (L). Cells were then lysed and
analyzed by sequential Western blotting for P-Tyr (705) Stat3 and total Stat3.
(D) Nanog is not a Stat3 target. ES cells expressing chimeric GCSFR-gp130 variant molecules in which the Stat3 binding sites are mutated
(Y126-275F) or in which the negative regulatory tyrosine is mutated (Y118F) were stimulated with LIF (L) or GCSF (G; 30 ng/ml) for the indicated
time (min). Northern analysis was performed by sequential hybridization with probes against Nanog, GAPDH, and SOCS3. Histogram shows
phosphoimager quantitation of the data for Y126-275F cells, with signals normalized to GAPDH.
(E) Nanog expression is not upregulated by MEK inhibitor. OKO160 ES cells carrying oct4-geo (Mountford et al., 1994) were cultured for 4
days in LIF, G418, and the indicated concentration of PD98059. RNA was analyzed by sequential Northern analysis with probes for nanog
and GAPDH.
(F) Nanog does not suppress Erk activation. ES cells expressing the nanog transgene and Cre-excised derivatives were plated at 105 cells/
cm2 and incubated overnight in LIF prior to cytokine withdrawal for 6 hr and stimulation with LIF () or mock (). Cell lysates prepared 10
min post stimulation were analyzed by sequential Western blotting for P-erk and erk.
(G) Nanog action requires maintenance of Oct4 expression. ZHBTc4.1 ES cells containing a doxycycline-responsive oct4 transgene and with
both alleles of endogenous oct4 deleted were transfected with pPyCAGIP derivatives carrying no insert (MT), Oct4, or Nanog. Cells were
cultured in the presence of LIF and absence (0) or presence (Dox) of doxycycline, which represses the Oct4 transgene. Following puromycin
selection, the percentage of undifferentiated colonies was determined.
via stimulation of a chimeric receptor (Y118F) lacking persuasively, Nanog expression is unaltered upon stim-
ulation of the hypersensitized chimeric receptor (Figurethe negative regulatory tyrosine (Burdon et al., 1999b)
results in enhanced and sustained induction of SOCS3. 7D). These data argue that Nanog expression is not
directly regulated by gp130 stimulation.In contrast to SOCS3, no change in Nanog expression
is evident upon LIF stimulation of native receptor. Most LIF-dependent ES cell self-renewal is enhanced by
Identification of ES Cell Determination Gene
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inhibition of the Erk mitogen activated kinase pathway tive self-renewal on ES cells. nanog expression vectors
support cytokine-independent ES cell propagation both(Burdon et al., 1999b). The Y118F chimeric receptor is
incapable of engaging the adaptor protein SHP2 and upon episomal transfection of polyoma T-containing
stem cells and following chromosomal integration. Thesethence coupling to the Ras-Erk pathway (Takahashi-
Tezuka et al., 1998). The absence of any change in results were obtained with several ES cell clones origi-
nating from three independent ES cell derivations, CCE,Nanog expression upon stimulation of this receptor sug-
gests that Erk signaling does not repress Nanog expres- CGR8, and E14Tg2a, and are therefore likely to be repre-
sentative for ES cells generally.sion. To confirm this point, ES cells were cultured in the
presence of the MEK inhibitor PD98059 (Dudley et al., The effect of Nanog is highly specific and is not repro-
duced by a panel of candidate cDNAs introduced into1995). To ensure comparability with untreated cultures,
differentiating cells were eliminated from the analysis ES cells, including Oct4 and two transcription factors,
Sox2 and FoxD3, identified as Oct4 partners and impli-by selection for Oct4 expression (Mountford et al., 1994).
Nanog expression was then evaluated (Figure 7E). cated in the pluripotency of epiblast by in vivo deletion
(Hanna et al., 2002; Avilion et al., 2003).Steady-state Nanog mRNA levels are unaltered in the
presence of MEK inhibitor, indicating that Erk1/2 signal- Forced expression of Nanog not only liberates ES
cells from the requirement for gp130 stimulation buting does not repress Nanog expression.
We examined whether Nanog overexpression influ- also reduces differentiation in response to retinoic acid,
3-methoxybenzamide, and, to a lesser extent, aggrega-ences Erk activation. Immunoblotting for phospho-Erk
shows that basal levels of activation of Erk1 and Erk2 tion. Cre-mediated excision of a floxed nanog transgene
restores cytokine dependence and multilineage differ-are indistinguishable between Nanog expressing ES
cells and their Cre revertants, and that Erks remain acti- entiation capacity of clonally expanded nanog transfec-
tants. This phenotype reversal, observed with multiplevatable in response to LIF stimulation in Nanog express-
ers (Figure 7F). independent clones, establishes a causal relationship
with Nanog expression. Introduction of the Cre-revertedWe explored the relationship between Nanog and
Oct4. Blastocysts from intercross matings of oct4 het- cells into mouse blastocysts results in embryo coloniza-
tion, contribution to fetal tissues, and the generationerozygous mice were analyzed for nanog mRNA by in
situ hybridization. We examined a total of 26 embryos, of healthy chimeric mice. We conclude that elevated
expression of nanog is sufficient to sustain the cardinalone in four of which are predicted to be homozygous.
All expressed nanog in the ICM as in Figure 4A. Oct4 attributes of ES cell identity.
protein is undetectable in homozygous embryos from
the 8-cell stage (Nichols et al., 1998). This result there- Expression and Function of Nanog
fore indicates that nanog transcription is induced in the nanog mRNA is found in pluripotent ES and EG cells
complete absence of Oct4. and in both mouse and human EC cells. Expression
The preceding observation also suggests that Nanog is downregulated early during ES cell differentiation,
is not sufficient to sustain pluripotency if Oct4 is deleted. consistent with an intimate association with pluripotent
We therefore tested the requirement for continued pres- stem cell identity. A recently reported homeodomain
ence of Oct4 for function of Nanog in ES cells. ZHBTc4.1 gene selectively expressed in ES cells is identical to
ES cells carry two null oct4 alleles and are sustained by Nanog (Wang et al., 2003). nanog is also represented in
a doxycycline-responsive Oct4 transgene (Niwa et al., an ES cell gene set described by microarray analysis
2000). When the Oct4 transgene is repressed by admin- (Ramalho-Santos et al., 2002). Indeed, Nanog is readily
istration of doxycycline, the cells differentiate. ZHBTc4.1 detectable in ES cell RNA by hybridization to the Affy-
cells were transfected with linearized pPyCAGIP se- metrix mouse U74Av2 genechip (T. Era, personal com-
quences carrying no insert, Oct4, or Nanog. As pre- munication; our unpublished data), but has not been
viously documented, the Oct4 plasmid prevented the reported in any other cell samples.
differentiation caused by doxycycline repression (Niwa Low expression of nanog in P19 cells, which are de-
et al., 2002). In contrast, the Nanog expression vector rived from and postulated to resemble cells of the egg
could not complement elimination of Oct4 and cells cylinder rather than the ICM, is consistent with the dy-
transfected with this plasmid differentiated in doxycy- namic profile of nanog mRNA in the embryo (Figure
cline (Figure 7G). Therefore, continued expression of 4). Nanog transcripts appear as a temporal wave with
Oct4 is essential for Nanog-mediated self-renewal. maximal levels between the late morula and the mid
We conclude that Nanog can bypass completely the blastocyst and downregulation just prior to implantation.
requirement for Stat3 activation and that maintained The restricted expression of Nanog coincides with the
expression of Oct4 is integral to its ability to sustain transient potential for ES cell generation, which arises
self-renewal. in the ICM and is lost around the time of implantation.
Epiblast expression of Nanog persists in implantation-
delayed blastocysts (data not shown), a favored source
Discussion for ES cell derivation (Brook and Gardner, 1997). Addi-
tionally, nanog mRNA is present in primordial germ cells
A Variant Homeodomain Protein Mediates in E11.5 gonadal ridges, the very cells that can be repro-
ES Cell Self-Renewal grammed to generate EG stem cells (Resnick et al.,
Through functional screening of an ES cell cDNA library, 1992). Thus, nanog is expressed in cells from which
we identified a previously unrecognized player in the it is possible to establish pluripotent stem cell lines.
stem cell self-renewal theater. Nanog is a homeodomain Expression of Oct4 overlaps with that of nanog but also
includes oocytes, early cleavage embryos and egg cylin-protein whose enhanced expression confers constitu-
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ders (Pesce and Scho¨ler, 2001); that is, both before and
after the window for stem cell derivation (Smith, 2001).
Cytokine stimulation of LIF-R/gp130 and consequent
activation of Stat3 is the only previously characterized
pathway for sustaining self-renewal of mouse ES cells.
The isolation of Nanog using LIF-R deficient ES cells
and clonal expansion of parental ES cells in the presence
of the LIF receptor blocking agent hLIF-05 demonstrates
that Nanog bypasses LIF-R/gp130 stimulation. Further-
more, Nanog supports stem cell colony formation in the
presence of the Jak inhibitor D6665, which abolishes
cytokine-mediated activation of Stats. The possibility
that Nanog might itself regulate Stat3 is ruled out by the
finding that Stat3 activation is unaltered and can be
completely abolished in Nanog transfectants. We con-
clude that Nanog can function independently of Stat3.
However, in the absence of gp130 stimulation, endog-
enous Nanog expression is insufficient to sustain self-
renewal. As nanog appears not to be a transcriptional
target of gp130, this implies that ES cells are normally
Figure 8. Model of the Transcription Factor Hierarchy in Pluripotentpropagated by collaboration between cytokine-acti-
Cellsvated Stat3 and an otherwise limiting amount of Nanog.
Both Nanog and Oct4 are essential to sustain ES cell identity,Consistent with this interpretation, dosage of Nanog is
whereas Stat3 has an accessory function. Oct4 serves a specificthe critical determinant of cytokine-independent colony
role in blocking differentiation into trophoblast but tends to promote
formation (Figure 7). Although increased Nanog renders differentiation into primitive endoderm and germ layers. Nanog (and
LIF-R/gp130 signaling dispensable, maximal self- activated Stat3) may block this differentiation effect of Oct4. Sup-
renewal is obtained by combination of Nanog overex- pression of differentiation by Nanog also maintains Oct4 transcrip-
tion, which is not downregulated unless the cells commit to differen-pression and LIF stimulation. Under these conditions,
tiate (dashed red line).peripheral differentiation is eliminated almost entirely
and ES cell colonies adopt a highly compacted morphol-
ogy, suggestive of a subtle change in cell adhesion prop- The activity of Nanog may explain the apparent para-
erties (Figure 5D). Thus, Nanog can act combinatorially dox that ES cells rely on cytokine stimulation while de-
with the gp130 signal. velopment of the ICM/epiblast proceeds normally in the
absence of gp130 or Stat3 (Yoshida et al., 1996; Takeda
et al., 1997). In an accompanying manuscript in thisThe Transcription Factor Network
for ES Cell Identity issue of Cell, Mitsui et al. (2003) show that Nanog is
required in the epiblast, indicating that it fulfils a similarThe presence of a homeodomain indicates that Nanog
is highly likely to act as a transcriptional regulator. How role in vivo as in ES cells. The downregulation of Nanog
mRNA expression at implantation (Figure 4A) may there-then does Nanog fit into the transcription factor hierar-
chy that dictates ES cell phenotype (Niwa, 2001; Smith, fore be critical to restrict expansion of the epiblast and
initiate egg cylinder formation. An obligate requirement2001)?
The dosage effect indicated for Nanog is also a feature for Nanog in the early embryo compared with the dis-
pensability of Stat3 is further evidence that Nanog ex-of Oct-4 (Niwa et al., 2000) and Stat3 (Niwa et al., 1998)
activity in ES cells. This suggests that the stoichiometry pression is not directed by, nor its function dependent
on, gp130/Stat3. However, the data do not rule out theof these factors is critical to provision of a robust frame-
work for self-renewal. The analysis in ZHBTc4 cells es- possibility of crosstalk between these two factors, and
indeed this seems likely given their collaborative effecttablishes that Nanog action requires continued pres-
ence of Oct4, implying that Nanog can determine Oct4 on ES cell self-renewal.
Currently, efforts are underway to identify a core pro-expression. This effect is likely to be indirect, however,
since Oct4 expression is not noticeably increased in gram of so-called “stemness” genes (Ramalho-Santos
et al., 2002). It is striking, however, that the functionalNanog overexpressers. Oct4 appears to be expressed
constitutively in ES cells and only downregulated upon identity of mouse ES cells depends on two master tran-
scription factors, Oct4 and Nanog, that are not detectedcommitment to differentiate (Fuhrmann et al., 2001).
Likewise, Oct4 seems not to be essential for Nanog in hematopoietic or neural stem cells (Ivanova et al.,
2002; Ramalho-Santos et al., 2002), nor in trophoblastexpression. Thus, these two factors act in concert rather
than in series (Figure 8). However, increased expression stem cells (our unpublished data). It will be of interest
to determine whether Nanog is expressed in multipotentof Oct4 causes ES cells to differentiate (Niwa et al.,
2000) whereas increased Nanog prevents differentia- adult progenitor cells (Jiang et al., 2002) and may there-
fore be generally associated with pluripotency, ortion. Therefore, Nanog may act to restrict the differen-
tiation-inducing potential of Oct4. A key question is whether it is truly unique to the ES cell phenotype. More
broadly, the regulation and interactions of Nanog andwhether Nanog interacts directly with Oct4 or acts in
parallel to determine expression/repression of key the nature of its target genes now emerge as central
issues in pluripotent stem cell biology.genes.
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Experimental Procedures RNA Analysis
Unless otherwise stated, we carried out Northern hybridizations on
10 g of total RNA. We used a digoxygenin-labeled ORF probe forES Cell Culture
ES cell lines used and their culture and differentiation are described in situ hybridization on cells and embryos.
elsewhere (Smith, 1991; Li et al., 1998). To prepare LRK1 cells, E14/T
cells (Aubert et al., 2002) were subjected to two rounds of gene Preparation of Cells Expressing a loxP
targeting aimed at the lifr locus (Li et al., 1995). The selectable Flanked Nanog Transgene
marker cassette was IRESBSDrpA and IREShphpA for the first and We prepared a cassette in which a synthetic polyadenylation se-
second rounds of targeting, respectively. LRK1 cells were main- quence and a MAZ site from the C2 gene (Ashfield et al., 1994)
tained in the presence of IL6 and sIL6R (Yoshida et al., 1994). precede a loxP site upstream of egfppA. This was introduced into
the pPyCAG-Nanog-IP vector, replacing the pA sequence 3 to the
pac gene. We inserted a loxP site within the rabbit -globin exoncDNA Library Construction and Characterization
of the CAG cassette to create the floxed Nanog vector. ES cellsWe prepared total RNA from ES cells cultured on 	-irradiated mouse
were transfected with linearized plasmid and selected in puromycinembryonic fibroblasts. Polyadenylated RNA (Oligotex, Qiagen) was
at 1 g/ml. Resistant colonies were picked and expanded. We thenevaluated by examination for 11 kb LIFR transcripts (Chambers et
plated cells at 100 cells/cm2 in nonselective medium supplementedal., 1997). cDNA was synthesized by oligo d(T) priming (Superscript
with hLIF-05 to block endogenous LIF. After 4 days, cells wereII, Life Technologies). cDNA  1 kb, recovered by electrophoretic
trypsinized to a single cell suspension and replated at 100 cells/fractionation and electroelution, was ligated into XhoI/NotI-digested
cm2. After a further 4–5 days, colonies of transfected ES cells hadpPyCAGIP to produce a library of 7.4 
 105 primary recombinants.
expanded, whereas similarly treated parental cells generated onlyOf 48 recombinants examined, 40 (83%) contained inserts, ranging
differentiated cells. LIF was then added, cells expanded, and stocksin size from 0.5–3.0 kb (average 1.5 kb). cDNAs for 16/27 well-
frozen. For Cre excision, cells were transiently transfected usingcharacterized genes extended 5 to the known initiator methionine
Lipofectamine 2000. Approximately 10 days later, colonies werecodon.
examined by fluorescent microscopy for GFP and expressing clones
expanded. Complete excision of the Nanog cassette was confirmedcDNA Library Transfection and Screening
by puromycin sensitivity.We introduced library (25 g) or empty vector into LRK1 cells (6 

106) by electroporation and seeded cells at 106 or 5 
 104 per 9 cm
Immunoblottingdish and cultured in IL6/sIL6R. After 2 days, puromycin was added
Steady state levels of activated Stat3 were measured by plating 106and cytokine was withdrawn from the high-density plates. Cytokine
cells onto a 10 cm2 dish in medium alone or supplemented with LIFwas maintained on the low-density plates to monitor transfection
(100 U/ml) or hLIF-05. Approximately 20 hr later, cells were lysed inefficiency. (We estimate that 7,200 clones were screened. We subse-
0.2 ml SDS sample buffer and 10 l aliquots analyzed for tyrosinequently screened a second independent library, and of an estimated
phosphorylated Stat3 (NEB antibody 9131) and total Stat3 (Trans-66,000 clones, the only active cDNA isolated encoded Nanog.) Me-
duction labs antibody S21320). Erk1/2 activation was determineddium was renewed every 2 days until 9 days posttransfection. Mock
as described (Burdon et al., 1999b).transfected plates and plates transfected with empty vector con-
tained no cells and only differentiated cells, respectively. In contrast,
colonies with undifferentiated cells were present on some of the Acknowledgments
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